Quantcast

Latest Vaccination Stories

2014-10-23 08:36:59

WORCESTER, Mass. and TORONTO, Oct. 23, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), will be participating in the 2014 BIO-Europe(®) Annual International Partnering Conference being held November 3-5 in Frankfurt, Germany. BIO-Europe(®) is Europe's largest partnering conference serving the global biotechnology industry. The conference...

2014-10-22 20:23:30

LONDON, Oct. 22, 2014 /PRNewswire/ -- This report focuses on the most recent vaccine research, emphasizing their reputation as an unmatched tool of efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance on the part of the target pathogen have been longstanding attributes of vaccines. Today, vaccine technology is undergoing a fundamental revolution, taking advantage of the profound understanding of the...

2014-10-22 04:22:17

NEW BRUNSWICK, N.J., Oct. 22, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program in development at its Janssen Pharmaceutical Companies. The company is closely collaborating with the World Health Organization (WHO), the National Institute of Allergy and Infectious Diseases (NIAID), as well as other key stakeholders, governments, and...

2014-10-21 08:35:47

WORCESTER, Mass. and TORONTO, Oct. 21, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that its wholly owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), has issued a white paper outlining the advantages of its Ii-Key technology in the development of an effective Ebola vaccine. Antigen Express has a proprietary technology platform focused on specific activation of critical components of the immune system. As purely...

2014-10-21 08:33:23

Humanitarian group's October 24 livestream event from Chicago features top global health experts, polio-survivor Minda Dentler, pop star Tessanne Chin, reggae's Ziggy Marley and more EVANSTON, Ill., Oct. 21, 2014 /PRNewswire-USNewswire/ -- With the world "This Close"--99%--to eliminating polio from the planet, the effort is receiving an additional US$44.7 million boost from Rotary to support immunization activities, surveillance, and research spearheaded by the Global Polio Eradication...

2014-10-21 08:32:32

PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune, the global biologics research and development arm of AstraZeneca. The group will develop DNA-based monoclonal antibodies...

2014-10-20 20:25:34

LONDON, Oct. 20, 2014 /PRNewswire/ -- Report DetailsYour guide to trends and revenue prospects for vaccine productionWhat's the outlook for producing vaccines? Visiongain's updated report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for those technologies. Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in the production of vaccines, helping your...

2014-10-16 08:27:40

NEW YORK, Oct. 16, 2014 /PRNewswire/ -- Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines. The healthcare market researcher said that two- to four-year-olds in the UK are for the first time to be offered for free an egg-based nasal vaccine. The intention is to prevent influenza (flu) in hopes of not just...

2014-10-14 20:23:26

CHICAGO, Oct. 14, 2014 /PRNewswire/ -- Pentamer Pharmaceuticals today announced that it has begun a crowdfunding campaign for the development of its Ebola vaccine. Dr. Stephen Hall, the Founder and CEO of Pentamer, developed a vaccine technology called NodaVax that has produced protective vaccines against other pathogens like Anthrax. Pentamer developed an Ebola vaccine (called NoBola) using this technology and has begun the crowdfunding campaign to help support vaccine...

2014-10-14 08:33:10

Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company, today announced that it has signed a definitive master service agreement with Pharmaceutical Product Development (PPD), a leading global contract research organization (CRO), to advance and expand clinical and regulatory development across...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin